B7-33 (6mg)

B7-33 (6mg) Research Peptide

Product Overview

B7-33 is a peptide analog of human relaxin-2, specifically designed to activate the RXFP1 receptor. Available in a 6mg vial, B7-33 is valuable in cardiovascular and fibrotic disease research. It enables scientists to study the mechanisms of heart function and fibrosis modulation.

Key Features

• Selective RXFP1 Agonist: Targets relaxin receptor pathways.
• High Purity: Purity over 98% confirmed by HPLC.
• Cardiovascular Research: Ideal for studies on heart failure and fibrosis.
• Stable Lyophilized Form: Facilitates long-term storage.

Specifications

• Molecular Formula: C162H258N48O50
• Molecular Weight: Approximately 3791.08 g/mol
• Appearance: White to off-white powder
• Quantity: 6mg per vial
• Purity: >98% (HPLC)
• Solubility: Soluble in sterile water or dilute acetic acid
• Storage Conditions: Store at -20°C, away from light

Potential Research Applications

• Heart Failure Studies: Exploring therapeutic targets for cardiac function.
• Fibrosis Research: Investigating anti-fibrotic mechanisms.
• Receptor Signaling: Studying RXFP1-mediated pathways.
• Vascular Biology: Understanding blood vessel function and repair.

Handling and Storage

• Reconstitution: Use sterile solvents for dissolution.
• Post-Reconstitution Storage: Keep aliquots at -20°C.
• Handling Precautions: Minimize exposure to air and light.

Safety and Compliance

• Research Use Only: Not for clinical or diagnostic use.
• Safety Measures: Follow standard laboratory safety protocols.
• Compliance: Ensure adherence to applicable regulations.

Disclaimer

This product is intended exclusively for laboratory research. It is not for use in humans or animals.